← Evidence map

ArticleThoracic cancer2022

Mubritinib enhanced the inhibiting function of cisplatin in lung cancer by interfering with mitochondrial function.

Jingyao Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35429141